CA-125-Antigen, page 16

Search results for CA-125-Antigen

Found 616 articles. Showing from 151 to 160.

Cancer (2009-03-25)
CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.

American journal of obstetrics and gynecology (2009-01-05)
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.

Radiology (2005-05-25)
Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.

Archives of ophthalmology (2010-11-09)
MUC16 as a sensitive and specific marker for epithelial downgrowth.

Gynecologic oncology (2008-12-22)
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.

Clinical and laboratory haematology (2005-02-02)
CA 125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies.

Gynecologic oncology (2011-07-18)
Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.

The Journal of reproductive medicine (1997-11-21)
Serum CA-125 measurements > 65 U/mL. Clinical value.

Journal of the National Cancer Institute (2007-11-21)
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.

Current opinion in obstetrics & gynecology (2002-01-21)
Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer.

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013